Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1125 | 966 | 1142 | 1303 | 1471 | 2209 |
Fund Return | 12.51% | -3.37% | 14.16% | 9.22% | 8.03% | 8.25% |
Place in category | 900 | 1829 | 788 | 783 | 795 | 450 |
% in Category | 42 | 88 | 37 | 45 | 52 | 46 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Handelsbanken Sverige Index A1 SEK | 66.77B | 8.73 | 0.09 | 9.61 | ||
Handelsbanken Sverige Index B1 SEK | 66.77B | 8.73 | 0.09 | 9.14 | ||
Handelsbanken MSCI USA Index | 55.09B | 35.80 | 16.17 | 17.39 | ||
Handelsbanken MSCI USA Index utd | 55.09B | 35.80 | 16.17 | 16.89 | ||
Handelsbanken Sverige OMXSB A1 SEK | 24.25B | 8.98 | 2.38 | 9.58 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SPP Aktiefond Europa | 18.07B | 15.05 | 10.88 | 9.08 | ||
Swedbank Robur Access Europa | 14.51B | 14.08 | 10.61 | 9.01 | ||
Handelsbanken Europafond Index | 13.02B | 12.51 | 9.21 | 8.73 | ||
Lansforsakringar Europa Indexnara | 11.22B | 11.27 | 8.94 | 8.49 | ||
AMF Aktiefond Europa | 8.14B | 9.40 | 8.32 | 8.73 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 3.79 | 589.2 | -20.72% | |
ASML Holding | NL0010273215 | 3.09 | 686.10 | -0.68% | |
SAP | DE0007164600 | 2.95 | 236.750 | -0.13% | |
Roche Holding Participation | CH0012032048 | 2.43 | 247.40 | +0.28% | |
Novartis | CH0012005267 | 2.42 | 86.72 | -0.37% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review